Head to Head Review: electroCore (NASDAQ:ECOR) versus QT Imaging (NASDAQ:QTI)

electroCore (NASDAQ:ECOR) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, profitability, institutional ownership and earnings.

Valuation & Earnings

This table compares electroCore and QT Imaging”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
electroCore	$16.03 million	4.58	-$18.83 million	($1.83)	-6.13
QT Imaging	N/A	N/A	-$4.03 million	N/A	N/A

QT Imaging has lower revenue, but higher earnings than electroCore.

Insider & Institutional Ownership

26.7% of electroCore shares are owned by institutional investors. Comparatively, 24.2% of QT Imaging shares are owned by institutional investors. 19.7% of electroCore shares are owned by company insiders. Comparatively, 75.4% of QT Imaging shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of recent ratings and recommmendations for electroCore and QT Imaging, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
electroCore	0	0	1	0	3.00
QT Imaging	0	0	0	0	0.00

Volatility and Risk

electroCore has a beta of 0.56, suggesting that its share price is 44% less volatile than the S&P 500. Comparatively, QT Imaging has a beta of -0.1, suggesting that its share price is 110% less volatile than the S&P 500.

Profitability

This table compares electroCore and QT Imaging’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
electroCore	-54.40%	-154.45%	-69.16%
QT Imaging	N/A	N/A	-65.94%

About electroCore

electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

About QT Imaging

QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient’s breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.